Four Firms Guide Pfizer's Latest Big Drug Buy
Wachtell, Ropes & Gray, Davis Polk and Cooley are advising on a $14 billion deal that will see pharmaceutical giant Pfizer Inc. acquire cancer drug maker Medivation Inc.
This premium content is reserved for American Lawyer subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now